| 1. Scientific full-length international papers SA Vreugdenhil, JM van Woerkom, YPM Goekoop-Ruiterman, ... Arthritis Care Res 69, 1473-83, 2017 | | 2017 |
| 25 Gold, antimalarials, sulfasalazine PLCM van Riel, EJJA Kroot Rheumatoid Arthritis: Frontiers in Pathogenesis and Treatment, 351, 2000 | | 2000 |
| 3 Evaluation of early rheumatoid arthritis disease activity and outcome AM van Gestel, PLCM van Riel Bailliere's clinical rheumatology 11 (1), 49-63, 1997 | 36 | 1997 |
| 4 Psychologische interventies bij reumatische aandoeningen J Jaspers, H van Middendorp, S van Koulil, FW Kraaimaat, ... Psychosociale zorg bij chronische ziekten: Klinische praktijk en …, 2010 | 5 | 2010 |
| 4 Treatment of early rheumatoid arthritis patients with slow-acting anti-rheumatic drugs (SAARDs) AM van Gestel, CJ Haagsma, DE Furst, PLCM van Riel Baillière's clinical rheumatology 11 (1), 65-82, 1997 | 31 | 1997 |
| 557 EVIDENCE-BASED TAILORED CONSERVATIVE TREATMENT OF KNEE AND HIP OA: BETWEEN KNOWING AND DOING G Snijders, A den Broeder, P van Riel, V Straten, H de Man, ... Osteoarthritis and Cartilage, S249-S250, 2010 | | 2010 |
| 80 Scientific Abstracts S Rollefstad, E Ikdahl, J Sexton, G Kitas, P Van Riel, CS Crowson | | |
| A 48-week long-term double-blind comparison of ß-cyclodextrin-piroxicam (Brexine®) with naproxen in ankylosing spondylitis MCW Creemers, MA van't Hof, M Franssen, FWJ Gribnau, ... marjonne с. ш. creemers, 17, 0 | | |
| A Clinical Audit of Cardiovascular Risk Factors and Disease in Patients with Rheumatoid Arthritis SURF-RA AG Semb, E Ikdahl, AM Kerola, G Wibetoe, J Sexton, CS Crowson, ... Mediterranean Journal of Rheumatology 33 (2), 201-217, 2022 | 7 | 2022 |
| A Comparison of CRP and ESR to Measure the DAS28 in Adalimumab Clinical Trials PL Van Riel, J Fransen, PM Welsing, H Kupper ANNALS OF THE RHEUMATIC DISEASES 62, 169-170, 2003 | 5 | 2003 |
| A comparison of the effectiveness of TNF Alpha blocking agents in the treatment of rheumatoid arthritis between randomized controlled trials and Dutch observational data W Kievit, J Fransen, HH Kuper, M van de Laar, D de Rooij, CMA de Gendt, ... EULAR Annual European Congress of Rheumatology 2006, 2006 | | 2006 |
| A core set of biomarkers as predictor of flare within one year after stopping TNF-inhibitor in established rheumatoid arthritis patients with sustained low disease activity … F Lamers-Karnebeek, MG Moghadam, HE Vonkeman, E Sasso, JJ Luime, ... Arthritis flare after stopping TNF inhibitor in RA: frequency …, 0 | | |
| A core set of domains for longitudinal observational studies in rheumatic disorders: consensus report from OMERACT 4 F Wolfe, M Lassere, D van der Heijde, G Stücki, M Suarez-Almazor, ... Arthritis Rheum 41 (Suppl 9), S204, 1998 | 2 | 1998 |
| A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis HJEM Janssens, J Fransen, EH Van de Lisdonk, PLCM van Riel, ... Archives of Internal Medicine 170 (13), 1120-1126, 2010 | 301 | 2010 |
| A different perspective: Inflammatory rheumatic diseases and other organs. GD Kitas, PL van Riel Best Practice & research. Clinical Rheumatology 30 (5), 787-788, 2016 | | 2016 |
| A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine. IH Nuver-Zwart, PL Van Riel, LB Van de Putte, FW Gribnau Annals of the rheumatic diseases 48 (5), 389-395, 1989 | 94 | 1989 |
| A Dutch version of the functional index for ankylosing spondylitis MCW Creemers, MA van't Hof, M Franssen, LBA van de Putte, ... marjonne с. ш. creemers, 99, 0 | | |
| A Dutch version of the functional index for ankylosing spondylitis: development and validation in a long-term study MCW Creemers, MA Van't Hof, M Franssen, LBA Van De Putte, ... Rheumatology 33 (9), 842-846, 1994 | 22 | 1994 |
| A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides L Bossini-Castillo, C De Kovel, H Kallberg, R van‘t Slot, A Italiaander, ... Annals of the rheumatic diseases 74 (3), e15-e15, 2015 | 86 | 2015 |
| A higher rate of serious infections in patients treated with TNF blocking agents W Kievit, MC Creemers, J Fransen, IH Kuper, M van de Laar, TL Jansen, ... ACR/ARHP Annual Scientific Meeting 2006, 2006 | | 2006 |
Timothy RadstakeHead Early Immunology Discovery Research, Abbvie在 abbvie.com 的电子邮件经过验证
